维普中文期刊产品整合服务
351篇 您的检索式:作者名="Parissis"
    题名 作者 年代 出处 被引量
1Association of arterial stiffness with coronary flow reserve in revascularized coronary artery disease patients显示文摘AIM: To investigate the association of arterial wave reflection with coronary flow reserve(CFR) in coronary artery disease(CAD) patients after successful revascularization.METHODS: We assessed 70 patients with angiographically documented CAD who had undergone recent successful revascularization. We measured(1) reactive hyperemia index(RHI) using fingertip peripheral arterial tonometry(RH-PAT Endo-PAT);(2) carotid to femoral pulse wave velocity(PWVc-Complior);(3) augmentation index(AIx), the diastolic area(DAI%) and diastolic reflection area(DRA) of the central aortic pulse wave(Arteriograph);(4) CFR using Doppler echocardiography; and(5) blood levels of lipoprotein-phospholipase A2(LpPLA2).RESULTS: After adjustment for age, sex, blood pressure parameter, lipidemic, diabetic and smoking status, we found that coronary flow reserve was independently related to AIx(b =-0.38, r = 0.009), DAI(b = 0.36, P = 0.014), DRA(b = 0.39, P = 0.005) and RT(b =-0.29,P = 0.026). Additionally, patients with CFR < 2.5 had higher PWVc(11.6 ± 2.3 vs 10.2 ± 1.4 m/s, P = 0.019), SBPc(139.1 ± 17.8 vs 125.2 ± 19.1 mm Hg, P = 0.026), AIx(38.2% ± 14.8% vs 29.4% ± 15.1%, P = 0.011) and lower RHI(1.26 ± 0.28 vs 1.50 ± 0.46, P = 0.012), DAI(44.3% ± 7.9% vs 53.9% ± 6.7%, P = 0.008), DRA(42.2 ± 9.6 vs 51.6 ± 11.4, P = 0.012) and Lp PLA2(268.1 ± 91.9 vs 199.5 ± 78.4 ng/m L, P = 0.002) compared with those with CFR ≥ 2.5. Elevated Lp PLA2 was related with reduced CFR(r =-0.33, P = 0.001), RHI(r =-0.37, P < 0.001) and DRA(r =-0.35, P = 0.001) as well as increased PWVc(r = 0.34, P = 0.012) and AIx(r = 0.34, P = 0.001). CONCLUSION: Abnormal arterial wave reflections are related with impaired coronary flow reserve despite successful revascularization in CAD patients. There is a common inflammatory link between impaired aortic wall properties, endothelial dysfunction and coronary flow impairment in CAD.Vlassis Tritakis Stavros Tzortzis Ignatios Ikonomidis Kleanthi Dima Georgios Pavlidis Paraskevi Trivilou Ioannis Paraskevaidis Giorgos Katsimaglis John Parissis John Lekakis 2016World Journal of Cardiology2016,8,2:4
2Association of Lp-PLA2 with digital reactive hyperemia, coronary flow reserve, carotid atherosclerosis and arterial stiffness in coronary artery disease显示文摘Ignatios Ikonomidis Nikolaos N.P. Kadoglou Vlassis Tritakis Ioannis Paraskevaidis Kleanthi Dimas Paraskevi Trivilou Ioannis Papadakis Stavros Tzortzis Helen Triantafyllidi John Parissis Maria Anastasiou-Nana John Lekakis 2014Atherosclerosis2014,,1:2
3Depression in coronary artery disease: Novel pathophysiologicmechanisms and therapeutic implications显示文摘Parissis JT Fountoulaki K Filippatos G 2007Int J Cardiol2007,116,2:1
4Lepirudin as an alternative to 'heparin allergy' during cardiopulmonary bypass显示文摘Parissis H 2011J Cardiothorac Surg2011,6,:1
5Effective sleep apnoea treatment improves cardiac function in patients with chronic heart failure显示文摘Spiros P. Kourouklis Emmanouil Vagiakis Ioannis A. Paraskevaidis Dimitrios Farmakis Konstantinos Kostikas John T. Parissis Apostolos Katsivas Dimitrios T. Kremastinos Maria Anastasiou-Nana Gerasimos Filippatos 2012International Journal of Cardiology2012,,:1
6Effects of darbepoetin - alpha on plasma pro - inflammatory cytokines, anti - inflammatory cytokine interleukin- 10 and soluble Fas/Fas ligand system in anemic patients with chronic heart failure 显示文摘Kourea K Parissis JT Farmakis D 2008Atherosclerosis2008,199,1:1
7Inotropes for the management of acute heart failure patients with renal dysfunction. Still an option?显示文摘Pinelopi Rafouli-Stergiou John T Parissis Maria Anastasiou-Nana 2012Expert Opinion on Pharmacotherapy2012,,:1
8Plasma profiles of peripheral monoeyte-related inflammatory markers in patients with arterial hypertension显示文摘Parissis JT Korovesis S Giazitzoglou E 2002Int J Cardiol2002,83,1:1
9Rationale and design of the multicenter randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study)显示文摘Altenberger J Parissis JT Ulmer H 2010Eur J Heart Fail2010,12,2:1
10Physical training modulates proinflammatory cytokines and the solube Fas/soluble Fas hgand system in patient with chronic heart failure显示文摘Adamopulos S Parissis Karatzas D 2002Cell Cardiol2002,39,4:1
11Anti-infammatory and anti-apoptotic effects of levosimendan in decomensated heart failure:a novel mechnism of drug-induced improvement in contractile performance of the failing heart显示文摘Paraskevaidis IA Parissis JT Kremastions D 2005Curr Med Chem Cardiovasc Hematol Agent2005,3,3:1
12Chalcopyrite thin film solar cells by electrodeposition 显示文摘LINCOT D GUILLEMOLESA J F TAUNIER S GUIMARD D SICX-KURDI J CHAUMONT A ROUSSEL O RAMDANI O HUBERT C FAUVARQUE J P BODEREAU N PARISSI L PANHELEUX P FANOUILLERE P NAGHAVI N GRAND P P BENFARAH M MOGENSEN P KERREC O 2004Solar Energy2004,77,:1
13Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches 显示文摘Koniari K Parissis J Paraskevaidis I 2012Eur Heart J Aute Cardiovasc Care2012,1,3:1
14Treating depression in coronary artery disease and chronic heart failure:what's new in using selective serotonin re-uptake inhibitors?显示文摘PARASKEVAIDIS I PALIOS J PARISSIS JG 2012Cardiovasc Hematol Agents Med Chem2012,10,2:1
15Etfects of darbepoetin o on right and left ventricular systolic and diastolic function in anemic patienLs withchronic heart failure secondary to ischemie or idiopathic dilated cardiomy- opathy 显示文摘Parissis JT Kourea K Panou F 2008Am Heart J2008,155,4:1
16Plasma B-typenat- riuretic peptide reduction predicts long-term response to levosi- mendan therapy in acutely decompensated chronic heart failure 显示文摘Farmakis D Parissis JT Bistola V eta1 2010IntJ Cardiol2010,139,1:1
17Haemodynamic effects of the use of the in-traaortic balloon pump 显示文摘PARISSIS H 2007Hellenic J Cardiol2007,48,6:1
18Dangerous drug interactions leading to hemolytic uremic syndrome following lung transplantation显示文摘Parissis H Gould K Dark J 2010J Cardiothorac Surg2010,5,:1
19Effects of levesimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure显示文摘 Adamopoulos S Antaniades C 2004Am J Cardiol2004,93,:1
20Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension: correlations with plasma endothelin-1显示文摘PARISSIS J T KOROVESIS S GIAZITZOGLOU E 2002Int J Cardiol2002,83,1:1
返回顶部 每页显示:
共18页 首页 上一页 第1页 下一页 末页 /18 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费